Guardant Health And ConcertAI Set Commercial Goals For Cancer Therapy Data-Sharing Deal
Partnership Brings Together Cancer Patient Clinical And Genomic Datasets
Guardant Health seeks to bring genomic cancer disease data into a clinical context in a new collaboration with ConcertAI aimed at designing cancer therapeutics and clinical trials, Amar Das, VP of real world evidence at Guardant Health, told Medtech Insight.
